Approval · Notice of Compliance 26025 · 2021
EFUDEX: Notice of Compliance 26025
Issued June 10, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26025
- Date
- June 10, 2021
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Change in product ownership. updates to the product monograph and inner and outer labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EFUDEX | 00330582 | Marketed |
Medicinal ingredients
- FLUOROURACIL 5 PER